B

Bioton SA
WSE:BIO

Watchlist Manager
Bioton SA
WSE:BIO
Watchlist
Price: 3.155 PLN -0.47% Market Closed
Market Cap: 270.9m PLN
Have any thoughts about
Bioton SA?
Write Note

Intrinsic Value

The intrinsic value of one BIO stock under the Base Case scenario is 4.078 PLN. Compared to the current market price of 3.155 PLN, Bioton SA is Undervalued by 23%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BIO Intrinsic Value
4.078 PLN
Undervaluation 23%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
Bioton SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BIO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BIO?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Bioton SA

Provide an overview of the primary business activities
of Bioton SA.

What unique competitive advantages
does Bioton SA hold over its rivals?

What risks and challenges
does Bioton SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bioton SA.

Provide P/S
for Bioton SA.

Provide P/E
for Bioton SA.

Provide P/OCF
for Bioton SA.

Provide P/FCFE
for Bioton SA.

Provide P/B
for Bioton SA.

Provide EV/S
for Bioton SA.

Provide EV/GP
for Bioton SA.

Provide EV/EBITDA
for Bioton SA.

Provide EV/EBIT
for Bioton SA.

Provide EV/OCF
for Bioton SA.

Provide EV/FCFF
for Bioton SA.

Provide EV/IC
for Bioton SA.

What are the Revenue projections
for Bioton SA?

How accurate were the past Revenue estimates
for Bioton SA?

What are the Net Income projections
for Bioton SA?

How accurate were the past Net Income estimates
for Bioton SA?

What are the EPS projections
for Bioton SA?

How accurate were the past EPS estimates
for Bioton SA?

What are the EBIT projections
for Bioton SA?

How accurate were the past EBIT estimates
for Bioton SA?

Compare the revenue forecasts
for Bioton SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bioton SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bioton SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bioton SA compared to its peers.

Compare the P/E ratios
of Bioton SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Bioton SA with its peers.

Analyze the financial leverage
of Bioton SA compared to its main competitors.

Show all profitability ratios
for Bioton SA.

Provide ROE
for Bioton SA.

Provide ROA
for Bioton SA.

Provide ROIC
for Bioton SA.

Provide ROCE
for Bioton SA.

Provide Gross Margin
for Bioton SA.

Provide Operating Margin
for Bioton SA.

Provide Net Margin
for Bioton SA.

Provide FCF Margin
for Bioton SA.

Show all solvency ratios
for Bioton SA.

Provide D/E Ratio
for Bioton SA.

Provide D/A Ratio
for Bioton SA.

Provide Interest Coverage Ratio
for Bioton SA.

Provide Altman Z-Score Ratio
for Bioton SA.

Provide Quick Ratio
for Bioton SA.

Provide Current Ratio
for Bioton SA.

Provide Cash Ratio
for Bioton SA.

What is the historical Revenue growth
over the last 5 years for Bioton SA?

What is the historical Net Income growth
over the last 5 years for Bioton SA?

What is the current Free Cash Flow
of Bioton SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bioton SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bioton SA

Current Assets 153.3m
Cash & Short-Term Investments 3.9m
Receivables 24.2m
Other Current Assets 125.2m
Non-Current Assets 645.8m
PP&E 306.5m
Intangibles 339.1m
Other Non-Current Assets 191k
Current Liabilities 147.3m
Accounts Payable 43.2m
Accrued Liabilities 15.4m
Other Current Liabilities 88.8m
Non-Current Liabilities 53.2m
Long-Term Debt 9.5m
Other Non-Current Liabilities 43.7m
Efficiency

Earnings Waterfall
Bioton SA

Revenue
186.3m PLN
Cost of Revenue
-123.3m PLN
Gross Profit
63m PLN
Operating Expenses
-61.1m PLN
Operating Income
1.9m PLN
Other Expenses
-8.7m PLN
Net Income
-6.8m PLN

Free Cash Flow Analysis
Bioton SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BIO Profitability Score
Profitability Due Diligence

Bioton SA's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Declining ROIC
44/100
Profitability
Score

Bioton SA's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

BIO Solvency Score
Solvency Due Diligence

Bioton SA's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Positive Net Debt
41/100
Solvency
Score

Bioton SA's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIO Price Targets Summary
Bioton SA

There are no price targets for BIO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BIO?

Click here to dive deeper.

Dividends

Bioton SA
does not pay dividends
Shareholder Yield

Current shareholder yield for BIO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Bioton SA

Country

Poland

Industry

Biotechnology

Market Cap

270.9m PLN

Dividend Yield

0%

Description

BIOTON SA engages in the manufacture and production of medicine and pharmaceutical substances. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 371 full-time employees. The company went IPO on 2005-03-16. The firm is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The firm's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.

Contact

WOJ. MAZOWIECKIE
Warsaw
ul. Staroscinska 5
+48227214000
bioton.com

IPO

2005-03-16

Employees

371

Officers

CEO & President of the Management Board
Mr. Jeremy Launders
Member of Management Board
Mr. Adam Tomasz Polonek
Senior Finance Manager
Ms. Anna Grabowska
Operations Director
Mr. Michal Deptuch
Chief Accountant
Renata Prokopczyk
Director of Legal Department
Ms. Kamila Musnicka
Show More
Head of Biolek Business Unit & CEO of Biolek Sp. Z O.O.
Mr. Mateusz Patryk Kosecki
Show Less

See Also

Discover More
What is the Intrinsic Value of one BIO stock?

The intrinsic value of one BIO stock under the Base Case scenario is 4.078 PLN.

Is BIO stock undervalued or overvalued?

Compared to the current market price of 3.155 PLN, Bioton SA is Undervalued by 23%.

Back to Top